Institutional Ownership Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). We have compiled data on the 214 institutions that hold shares in the stock, with a total of 114 Million shares, which have been reported (via 13F filing form) to have a value of $329 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,983,662
shares
|
$40.6 Million
0.0% of portfolio
|
Q2 2024
Added 392.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
12,092,449
shares
|
$35.1 Million
0.0% of portfolio
|
Q3 2025
Added 3.21%
|
|
|
Two Seas Capital LP
Rye, NY |
Nov 14, 2025 Q3 2025 |
9,749,724
shares
|
$28.3 Million
0.51% of portfolio
|
Q3 2025
Reduced 2.06%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Nov 14, 2025 Q3 2025 |
7,061,857
shares
|
$20.5 Million
0.1% of portfolio
|
Q3 2025
Reduced 31.71%
|
|
|
Pender Fund Capital Management Ltd.
Vancouver, A1 |
Nov 14, 2025 Q3 2025 |
6,676,519
shares
|
$19.4 Million
7.68% of portfolio
|
Q2 2025
Added 233.83%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
4,751,396
shares
|
$13.8 Million
0.0% of portfolio
|
Q3 2025
Added 3.65%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
4,478,834
shares
|
$13 Million
0.0% of portfolio
|
Q3 2025
Added 19.16%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
4,055,626
shares
|
$11.8 Million
0.0% of portfolio
|
Q3 2025
Added 284.24%
|
|
|
Meditor Group LTD
|
Oct 07, 2024 Q3 2024 |
3,791,300
shares
|
$11 Million
12.99% of portfolio
|
Q3 2023
Reduced 13.89%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
3,711,069
shares
|
$10.8 Million
0.0% of portfolio
|
Q3 2025
Added 778.12%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,119,253
shares
|
$9.05 Million
0.0% of portfolio
|
Q4 2024
Added 48.61%
|
|
|
Aigh Capital Management LLC
Baltimore, MD |
Oct 31, 2025 Q3 2025 |
3,000,000
shares
|
$8.7 Million
1.32% of portfolio
|
Q3 2025
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
2,521,439
shares
|
$7.31 Million
0.01% of portfolio
|
Q3 2025
Reduced 52.54%
|
|
|
Royce & Associates LP
|
Nov 12, 2025 Q3 2025 |
2,293,488
shares
|
$6.65 Million
0.07% of portfolio
|
Q3 2025
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,238,618
shares
|
$6.49 Million
0.01% of portfolio
|
Q3 2025
Added 22.46%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
1,953,058
shares
|
$5.66 Million
0.0% of portfolio
|
Q3 2025
Added 223.47%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
1,908,000
shares
|
$5.53 Million
0.01% of portfolio
|
Q3 2025
Reduced 8.87%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,848,437
shares
|
$5.36 Million
0.0% of portfolio
|
Q3 2025
Added 3.6%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,708,807
shares
|
$4.96 Million
0.0% of portfolio
|
Q3 2025
Added 113.93%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,530,364
shares
|
$4.44 Million
0.0% of portfolio
|
Q3 2025
Reduced 34.29%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
1,500,000
shares
|
$4.35 Million
0.3% of portfolio
|
Q3 2025
New holding
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,246,310
shares
|
$3.61 Million
0.0% of portfolio
|
Q3 2025
Reduced 18.92%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
974,856
shares
|
$2.83 Million
0.0% of portfolio
|
Q3 2025
Added 115.37%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
954,449
shares
|
$2.77 Million
0.0% of portfolio
|
Q3 2025
Added 14.11%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
945,491
shares
|
$2.74 Million
0.0% of portfolio
|
Q3 2025
Reduced 50.8%
|
|